Robarts Clinical Trials Revenue and Competitors

London, ON CAN

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Robarts Clinical Trials's estimated annual revenue is currently $126M per year.(i)
  • Robarts Clinical Trials's estimated revenue per employee is $201,000

Employee Data

  • Robarts Clinical Trials has 627 Employees.(i)
  • Robarts Clinical Trials grew their employee count by 14% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.5M92-1%N/AN/A
#2
$14.3M716%N/AN/A
#3
$36M1798%N/AN/A
#4
$7.8M398%N/AN/A
#5
$17.9M933%$192.2MN/A
#6
$64.9M3234%N/AN/A
#7
$0.5M5-55%N/AN/A
#8
$6.8M34-41%N/AN/A
#9
$19.5M9723%N/AN/A
#10
$2.5M2519%N/AN/A
Add Company

Robarts Clinical Trials is an internationally recognized full-service Contract Research Organization. Since 1986 we have collaborated with pharmaceutical and biotechnology industries, government agencies, and academic investigators in the performance of global, multi-centre, randomized controlled trials. We integrate content area expertise with practical hands-on experience in managing the many aspects of a trial. Our proven expertise enables you to achieve maximum efficiency for your research.

keywords:N/A

N/A

Total Funding

627

Number of Employees

$126M

Revenue (est)

14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Robarts Clinical Trials's People

NameTitleEmail/Phone
1
Director, Quality AssuranceReveal Email/Phone
2
Desktop Support SpecialistReveal Email/Phone
3
Manager, Document ManagementReveal Email/Phone
4
Director FinanceReveal Email/Phone
5
Team Lead, TMF OperationsReveal Email/Phone
6
Administration AssistantReveal Email/Phone
7
Sr. Clinical Operations Lead (Sr. Lead CRA)Reveal Email/Phone
8
Director, Medical OperationsReveal Email/Phone
9
Data ManagerReveal Email/Phone
10
Business Development Director Europe and Asia PacificReveal Email/Phone

Robarts Clinical Trials News

2022-04-06 - Difficult-to-treat inflammatory bowel disease: results from a ...

VJ has received consulting and advisory board fees from AbbVie, Alimentiv (formerly Robarts Clinical Trials), Arena Pharmaceuticals, Asahi Kasei Pharma,...

2022-03-30 - Morphic Therapeutic Announces Initiation of EMERALD-1 ...

Phase 2b EMERALD-2 clinical trial of MORF-057 expected to begin mid-year 2022 ... The primary endpoint of the trial is the change in Robarts...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$103.5M627-2%N/A
#2
$79.9M6276%N/A
#3
$227.3M62726%N/A
#4
$258.6M6272%N/A
#5
$137.4M6285%N/A